Open original FDA record ↗Recall record
- FDA identifier
- Z-1704-2016
- Company in FDA record
- Leica Microsystems, Inc.
- FDA record creation date
- May 21, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Novocastra Liquid Mouse Monoclonal Antibody Calretinin when used in combination with specific Lots of antibody diluent will give reduced staining.
Source facts
- Action
- A Medical Device Recall Notification letter was sent via e-mail on April 5, 2015 to the consignees describing the nature of the recall and action that needed to be taken. The firm requested that the consignees take the following actions: Only use Novocastra Liquid Mouse Monoclonal Antibody Calretinin with the lot numbers of diluent specified. There is no need for retrospective review of tissue staining if appropriate positive controls were properly used and interpreted during the immuno / in situ staining. Complete and return the attached acknowledgment. The firm requests that consignees contact their local Leica representative if they have any questions or concerns, or alternatively please contact the firm at the following e-mail address; LMGRA@leica-microsystems.com
- Initiated
- 2016-03-22
- Root cause
- Nonconforming Material/Component
- Terminated
- 2017-11-30
- Distribution
- Worldwide Distribution -- U.S., to the following states: AK, CA, FL, GA, MN, MT, NJ, OH, TX and WA; and, the country of Canada.
- Recall number
- Z-1704-2016
- Recall status
- Terminated
- CDRH record ID
- 145056
- FDA record created
- 2016-05-21
- Recall event number
- 73823